ContraFect
CFRX
$0.05000
Share price
-27.95%
Change (1 day)
-97.77%
Change (1 year)
Categories
ContraFect (CFRX) - P/B ratio
P/B ratio as of May 2024 : -0.0929
According to ContraFect's latest financial reports the company has a price-to-book ratio of -0.0929.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ContraFect - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.0646 | -79.73% |
| 2022-12-31 | -0.3186 | -115.21% |
| 2021-12-31 | 2.10 | -81.17% |
| 2020-12-31 | 11.1 | 81.78% |
| 2019-12-31 | 6.12 | -72.07% |
| 2018-12-31 | 21.9 | 819.22% |
| 2017-12-31 | 2.38 | -36.04% |
| 2016-12-31 | 3.73 | -12.37% |
| 2015-12-31 | 4.26 | 53.85% |
| 2014-12-31 | 2.77 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | 9.09 | -9,878.52% | 🇺🇸 USA |
 Prometheus Biosciences RXDX | 13.7 | -14,842.57% | 🇺🇸 USA |